ADENOCARCINOMA
Clinical trials for ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted lung cancer drug tested against chemo in phase 3 trial
Disease control TerminatedThis study tested a new targeted pill, pralsetinib, against standard chemotherapy for people with a specific type of advanced lung cancer (RET fusion-positive) who had not yet received treatment. The goal was to see if the targeted drug could delay cancer growth better than chemo…
Matched conditions: ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 17, 2026 03:17 UTC
-
Kidney cancer combo trial halted early – what we know
Disease control TerminatedThis study tested two new drug combinations for people with advanced clear cell kidney cancer that had already been treated. The goal was to see if adding the experimental drug NKT2152 to standard therapies could shrink tumors or slow the disease. The trial was stopped early, so …
Matched conditions: ADENOCARCINOMA
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Genome-Guided lung cancer treatment study halted early
Knowledge-focused TerminatedThis study aimed to see if using genome sequencing could help doctors choose better treatments for people with multiple lung adenocarcinoma tumors. Researchers planned to enroll 100 adults with early-stage, non-spread lung cancer. The study was terminated early, so results are li…
Matched conditions: ADENOCARCINOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 11, 2026 20:51 UTC